K Vandenbroeck (UPV)

The group focuses on the identification and functional characterization of genes involved in the pathogenesis of multiple sclerosis, as well as on novel anti-inflammatory therapies.

The main contributions to REEM are:

  1. Identification and validation of MS risk genes in the Spanish population in collaboration with E Urcelay, F Matesanz, M Comabella.
  2. Pharmacogenomics of MS therapies in collaboration with M Comabella, G Izquierdo/F Matesanz, E Urcelay.
  3. Analysis of the role of immune response in CNS damage in collaboration with P Villoslada/Garcia-Ojalvo, O Fernandez, F de Castro and C Guaza.
  • Publicaciones del grupo:

    PubMed